Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Invesco India PSU Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Invesco | HDFC |
| NAV | ₹76.3600 | ₹23.6750 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 13.9 years | 3.1 years |
| Expense ratio | 1.2% | 1.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 51.50 | 94.50 |
Returns
| Invesco India PSU Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | +4.15% | +12.97% |
| 3 months | −3.51% | +7.13% |
| 6 months | −2.65% | +17.84% |
| YTD | −3.29% | +33.73% |
| 1 year | −4.19% | +32.20% |
| 3 years (CAGR) | +17.36% | +30.70% |
| 5 years (CAGR) | +20.13% | — |
| 10 years (CAGR) | +16.18% | — |
| Since launch | +15.43% | +31.83% |
Risk
| Invesco India PSU Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | 23.6% | 15.8% |
| Downside volatility | 14.3% | 8.5% |
| Sharpe | 0.46 | 1.53 |
| Sortino | 0.76 | 2.86 |
| Calmar | 0.58 | 2.06 |
| Return / risk | 0.74 | 1.95 |
| Deepest fall | −33.42% | −14.91% |
| Days to recover | 289 | 126 |
| Below its high | −8.06% | +0.00% |
Against benchmark
| Invesco India PSU Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | — | +7.54% |
| Beta | — | 0.97 |
| R² | — | 85.0% |
| Up capture | — | 108.9% |
| Down capture | — | 71.0% |
| Tracking error | — | 6.1% |
| Information ratio | — | 1.17 |
| Treynor | — | 0.24 |
Consistency
| Invesco India PSU Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +116.73% | +67.01% |
| Middle 1-year | +14.92% | +23.25% |
| Worst 1-year | −23.48% | +1.71% |
| 1-year periods with a loss | 23.0% | 0.0% |
| Middle 3-year | +18.21% | +30.22% |
| Positive months | 55.6% | 72.2% |
| Best day | +6.78% | +3.18% |
| Worst day | −14.78% | −3.61% |
| Worst 5% day | −2.16% | −1.51% |
| Positive days | 55.7% | 58.3% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Invesco India PSU Equity Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | +17.43% | — |
| 5-year value | ₹9,35,042 | — |
| 3-year XIRR | +4.67% | +27.71% |
| 1-year XIRR | −3.90% | +41.37% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.